2026. 9.1-9.3

上海新国际博览中心 N1-N4

距离展会

Sustainable textile coatings for medical applications

In recent years, Covestro has developed new polyurethane raw materials for state-of-the-art wound care under the trade name of Baymedix®. These include raw materials for wound dressings that assist in the healing process and also offer numerous design options. These raw materials are used, for example, in absorbent foams manufactured from Baymedix® FP, adhesives with skin contact made of Baymedix® A and films based on the waterborne products Baymedix® FD and CD.

A new focus of Covestro’s material developments are applications in medical textile coatings, for example in surgical clothing, mattress pads for hospitals, coatings for medical furniture and medical bandages. The company is presenting its raw materials for sustainable waterborne textile coatings that have good tactile properties and improved resistance to disinfectants at the Compamed trade show in Düsseldorf, Germany, from November 14 to 17. These materials are also suitable for latex-free elastic self-adhesive bandages and secondary fixing. 

Covestro is additionally showcasing material solutions with thermoplastic polyurethane films and the high-performance plastic polycarbonate (PC) that fulfill the demands of both medical technology manufacturers and patients.


About Covestro:
With 2015 sales of EUR 12.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. Covestro, formerly Bayer MaterialScience, has 30 production sites around the globe and as of the end of 2015 employed approximately 15,800 people (full-time equivalents).

Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/Coves

2026上海医疗器械展览会|国内脉冲电场消融技术全景分析:从技术突破到未来演进

2026上海医疗器械展览会了解到,脉冲电场消融(Pulsed Field Ablation, PFA)作为心脏电生理领域近十年来最具颠覆性的创新技术,正在从根本上改变房颤等心律失常的治疗范式。本文基于国家药品监督管理局官方数据、企业公开信息、临床研究文献及行业分析报告,对国内PFA技术进行系统性梳理。文章首先阐释PFA区别于传统热消融的核心技术原理与组织选择性优势;其次,详细盘点截至2026年初已获批的国产PFA产品,从技术路线、临床数据、产品特点等维度进行对比分析;再次,对当前市场竞争格局与市场份额分布进行深入剖析;最后,从波形优化、三维整合、适应症拓展、联合治疗及智能化等方向,解析PFA技术的未来演进路径。本文旨在为医疗器械行业从业者、临床医生及政策制定者提供一份全面、深入、前瞻的参考。

查看更多 »

感谢您关注Medtec 国际医疗器械设计与制作技术展览会
预登记将于20264月开启
敬请期待